Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Autogenous Vaccines Market: By Strain Type: Bacterial Strain, Virus Strain; By End Use: Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments
Global Autogenous Vaccines Market Outlook
The global autogenous vaccines market is expected to grow at a CAGR of 4.3% in the forecast period of 2021-2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Provision of Funds by Several Governments is Aiding the Growth of Autogenous Vaccines Industry
The market for autogenous vaccines is driven by the rising provision of funds by several governments and international communities of public and private benefactors for the control and eradication programmes. For example, European Animal Health Strategy Programs have contributed significantly to the industry. The rising focus of government organisations towards the immunisation of animals is expected to propel the market growth over the forecast period. Further, the international agencies and organisations like Center for Disease Prevention and Control, Food and Agriculture Organization, and World Organization for Animal Health (OIE) have significantly contributed to the reduction of animal diseases and regulating and controlling programmes for animal diseases. Besides, the market is influenced by the growing focus on innovations for the prevention and treatment of zoonotic diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Autogenous Vaccines: Industry Definition and Segmentation
An autogenous vaccine is refers to a vaccine that is developed from cultures of microorganisms accumulated from individuals and then used to immunise the same individual against further propagation and development of the same microorganisms.
On the basis of strain type, the market is divided into:
- Bacterial Strain
- Virus Strain
Based on end use, the industry can be segmented into:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Prevalence of Contagious Diseases to Aid the Market Growth of Autogenous Vaccines Industry
The market for autogenous vaccines is driven by the rising prevalence of contagious diseases across the globe as it is generating demand for customised autogenous vaccines. Animals are susceptible to a wide range of contagious diseases like pink eyes and peste des petits ruminants (PPR) / goat plague, a highly contagious disease that generally affects ruminants. As reported by the Food and Agricultural Organization, peste des petits ruminants (PPR) virus or goat plague can contaminate approximately 90% of small ruminant inhabitants. The outbreak of contagious diseases severely interrupts livestock production, leading to direct and indirect financial losses. The government organisations as well as public organisations contribute the economic resources for the prevention and control of contagious infection in livestock, which is expected to facilitate the market growth of autogenous vaccines during the forecast period.
Key Industry Players in the Global Autogenous Vaccines Market
The report gives a detailed analysis of the following key players in the global autogenous vaccines market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Newport Laboratories, Inc.
- Elanco Animal Health Inc.
- Cambridge Technologies
- Hygieia Biological Laboratories
- AniCon Labor GmbH
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Strain Type, End Use, Region |
| Breakup by Strain Type | Bacterial Strain, Virus Strain |
| Breakup by End Use | Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Newport Laboratories, Inc., Elanco Animal Health Inc., Cambridge Technologies, Hygieia Biological Laboratories, AniCon Labor GmbH, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Autogenous Vaccines Market Analysis
8.1 Key Industry Highlights
8.2 Global Autogenous Vaccines Historical Market (2016-2020)
8.3 Global Autogenous Vaccines Market Forecast (2021-2026)
8.4 Global Autogenous Vaccines Market by Strain Type
8.4.1 Bacterial Strain
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Virus Strain
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.5 Global Autogenous Vaccines Market by End Use
8.5.1 Veterinary Clinics
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Veterinary Hospitals
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 Veterinary Research Institutes
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2016-2020)
8.5.3.3 Forecast Trend (2021-2026)
8.5.4 Others
8.6 Global Autogenous Vaccines Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Newport Laboratories, Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Elanco Animal Health Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Cambridge Technologies
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Hygieia Biological Laboratories
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 AniCon Labor GmbH
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Autogenous Vaccines Market: Key Industry Highlights, 2016 and 2026
2. Global Autogenous Vaccines Historical Market: Breakup by Strain Type (USD Billion), 2016-2020
3. Global Autogenous Vaccines Market Forecast: Breakup by Strain Type (USD Billion), 2021-2026
4. Global Autogenous Vaccines Historical Market: Breakup by End Use (USD Billion), 2016-2020
5. Global Autogenous Vaccines Market Forecast: Breakup by End Use (USD Billion), 2021-2026
6. Global Autogenous Vaccines Historical Market: Breakup by Region (USD Billion), 2016-2020
7. Global Autogenous Vaccines Market Forecast: Breakup by Region (USD Billion), 2021-2026
8. North America Autogenous Vaccines Historical Market: Breakup by Country (USD Billion), 2016-2020
9. North America Autogenous Vaccines Market Forecast: Breakup by Country (USD Billion), 2021-2026
10. Europe Autogenous Vaccines Historical Market: Breakup by Country (USD Billion), 2016-2020
11. Europe Autogenous Vaccines Market Forecast: Breakup by Country (USD Billion), 2021-2026
12. Asia Pacific Autogenous Vaccines Historical Market: Breakup by Country (USD Billion), 2016-2020
13. Asia Pacific Autogenous Vaccines Market Forecast: Breakup by Country (USD Billion), 2021-2026
14. Latin America Autogenous Vaccines Historical Market: Breakup by Country (USD Billion), 2016-2020
15. Latin America Autogenous Vaccines Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Middle East and Africa Autogenous Vaccines Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Middle East and Africa Autogenous Vaccines Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Global Autogenous Vaccines Market Structure
Key Questions Answered in the Report
The global autogenous vaccines market is projected to grow at a CAGR of 4.3% between 2021 and 2026.
The major drivers of the industry, such as rising disposable incomes, increasing population, rising prevalence of contagious diseases, changing lifestyles, and growing government funding, are expected to aid the market growth.
The key market trend guiding the growth of the market includes the growing focus on innovations for the prevention and treatment of zoonotic diseases.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading strain types in the market are bacterial strain and virus strain.
The major end use sectors in the market are veterinary clinics, veterinary hospitals, and veterinary research institutes, among others.
The major players in the industry are Newport Laboratories, Inc., Elanco Animal Health Inc., Cambridge Technologies, Hygieia Biological Laboratories, and AniCon Labor GmbH, among others.
Analyst Review
The global autogenous vaccines market is being driven by the growing prevalence of contagious diseases. Aided by the rising innovations, the market is expected to witness a moderate growth in the forecast period of 2021-2026, growing at a CAGR of 4.3%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on strain type, the market is segmented into bacterial strain and virus strain. By end use, the industry is divided into veterinary clinics, veterinary hospitals, and veterinary research institutes, among others. The major regional markets for autogenous vaccines are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Newport Laboratories, Inc., Elanco Animal Health Inc., Cambridge Technologies, Hygieia Biological Laboratories, and AniCon Labor GmbH, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global telmisartan market attained a value of about USD 3,574 million in 2020, driven by the rising cases of hypertension and cardiovascular diseases. Aided by the robustly growing pharmaceutical ...
The global doxorubicin market attained a value of about USD 1,075.90 million in 2020, driven by the rising cases of cancer worldwide. Aided by government investments in the pharmaceutical sector, the ...
The global radiopharmaceuticals market attained a value of about USD 4.3 billion, driven by rising applications in diagnostic and therapeutic segment. Aided by constant research and development and ri...
The global anticoagulants market is driven by the rising prevalence of various cardiovascular diseases. Aided by the growing adoption of safer and more efficient anticoagulants, the market is expected...
The global acne medication market attained a value of nearly USD 8.9 billion in 2020, driven by the rising prevalence of acne disorders and the growing advancements in developing acne treatment soluti...
NEWSLETTER